- Home
- Publications
- Publication Search
- Publication Details
Title
Glycans as Targets for Drug Delivery in Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 4, Pages 911
Publisher
MDPI AG
Online
2022-02-14
DOI
10.3390/cancers14040911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development
- (2021) Harleen Kaur CRITICAL REVIEWS IN BIOTECHNOLOGY
- The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
- (2021) Yonghui Liu et al. International Journal of Nanomedicine
- Antibody-Mediated Drug Delivery
- (2021) Fatma Betul Arslan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and Characterization of PLGA‐Based Multistage Delivery System for Enhanced Payload Delivery to Targeted Vascular Endothelium
- (2021) Jorge A. Palma‐Chavez et al. MACROMOLECULAR BIOSCIENCE
- The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
- (2021) Benjamin A. H. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-CEA tagged iron nanoparticles for targeting triple-negative breast cancer
- (2021) Thais S Correa et al. Biomedical Materials
- Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
- (2021) Alice L. Yu et al. CLINICAL CANCER RESEARCH
- Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
- (2021) Fernanda Andrade et al. JOURNAL OF CONTROLLED RELEASE
- Unlocking the potential of antibody–drug conjugates for cancer therapy
- (2021) Joshua Z. Drago et al. Nature Reviews Clinical Oncology
- Recent advances on smart glycoconjugate vaccines in infections and cancer
- (2021) Marko Anderluh et al. FEBS Journal
- ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab
- (2021) Henrique O. Duarte et al. ONCOGENE
- Machine learning guided aptamer refinement and discovery
- (2021) Ali Bashir et al. Nature Communications
- Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells
- (2021) Joana G. Rodrigues et al. CELLULAR ONCOLOGY
- Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
- (2021) Mariam Elshiaty et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanoparticle T cell engagers for the treatment of acute myeloid leukemia
- (2021) Kinan Alhallak et al. Oncotarget
- The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal Glycosylation
- (2021) Fabio Dall’Olio et al. Cancers
- Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
- (2021) D.V.T. Catenacci et al. ESMO Open
- The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins
- (2020) Fanqi Jin et al. GLYCOCONJUGATE JOURNAL
- Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
- (2020) Eunus S. Ali et al. SEMINARS IN CANCER BIOLOGY
- Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
- (2020) A.C. Marques et al. JOURNAL OF CONTROLLED RELEASE
- Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults
- (2020) Benjamin H. Goldenson et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody–Drug Conjugates for Cancer Therapy
- (2020) Umbreen Hafeez et al. MOLECULES
- Global view of human protein glycosylation pathways and functions
- (2020) Katrine T. Schjoldager et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer
- (2020) Divya Thomas et al. MOLECULAR THERAPY
- Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery
- (2020) Sergio Andrés Torres-Pérez et al. Frontiers in Oncology
- Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
- (2020) Ye Liang et al. Bioactive Materials
- O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype
- (2019) Daniela Freitas et al. EBioMedicine
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- O‐glycan truncation enhances cancer‐related functions of CD 44 in gastric cancer
- (2019) Stefan Mereiter et al. FEBS LETTERS
- Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages
- (2019) Jun Ye et al. International Journal of Nanomedicine
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
- (2019) Stefan Mereiter et al. CANCER CELL
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles
- (2019) Ruoning Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
- (2019) Heinz Läubli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Truncated O‐glycans promote epithelial‐to‐mesenchymal transition and stemness properties of pancreatic cancer cells
- (2019) Divya Thomas et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase
- (2019) Xin Yu Koh et al. ONCOGENE
- Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential
- (2019) Elisabete Fernandes et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2019) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
- (2019) Sibi Raj et al. SEMINARS IN CANCER BIOLOGY
- Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
- (2019) Francis W. Hunter et al. BRITISH JOURNAL OF CANCER
- Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
- (2019) Sagar Lonial et al. LANCET ONCOLOGY
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
- (2019) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glyco-nanoparticles: New drug delivery systems in cancer therapy
- (2019) Haroon Khan et al. SEMINARS IN CANCER BIOLOGY
- Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment
- (2018) Marina Martínez-Carmona et al. Acta Biomaterialia
- Multifunctional GQDs-Concanavalin A@Fe 3 O 4 nanocomposites for cancer cells detection and targeted drug delivery
- (2018) Ankan Dutta Chowdhury et al. ANALYTICA CHIMICA ACTA
- Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
- (2018) Fan Niu et al. BIOMATERIALS
- Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer
- (2018) Maryna Perepelyuk et al. MOLECULAR PHARMACEUTICS
- Lectin-gated and glycan functionalized mesoporous silica nanocontainers for targeting cancer cells overexpressing Lewis X antigen
- (2018) R. Bhat et al. Nanoscale
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
- (2018) Colleen M. Britain et al. Journal of Ovarian Research
- Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6
- (2018) Patrick J. Kennedy et al. Acta Biomaterialia
- Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells
- (2018) Inês Pereira et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A Mechanism of Resistance to Antibody-Targeted Immune Attack
- (2018) Dalal S Aldeghaither et al. Cancer Immunology Research
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Selectins in cancer immunity
- (2017) Lubor Borsig GLYCOBIOLOGY
- Antibody fragments as nanoparticle targeting ligands: a step in the right direction
- (2017) Daniel A. Richards et al. Chemical Science
- The Cosmc connection to the Tn antigen in cancer
- (2017) Tongzhong Ju et al. Cancer Biomarkers
- Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer
- (2016) Stefan Mereiter et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein
- (2016) Hui Cai et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Current Challenges in Cancer Treatment
- (2016) Jon Zugazagoitia et al. CLINICAL THERAPEUTICS
- The Role of Sialyl-Tn in Cancer
- (2016) Jennifer Munkley INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance
- (2016) E. Allen Sickmier et al. PLoS One
- Protein Glycosylation in Cancer
- (2015) Sean R. Stowell et al. Annual Review of Pathology-Mechanisms of Disease
- Selectins: initiators of leucocyte adhesion and signalling at the vascular wall
- (2015) Rodger P. McEver CARDIOVASCULAR RESEARCH
- LC–MS/MS glycomic analyses of free and conjugated forms of the sialic acids, Neu5Ac, Neu5Gc and KDN in human throat cancers
- (2015) Fang Wang et al. GLYCOBIOLOGY
- CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia
- (2015) Hong Li et al. MOLECULAR PHARMACEUTICS
- Assessing the relative efficacy of new drugs: an emerging opportunity
- (2015) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- In Vitro Administration of Gold Nanoparticles Functionalized with MUC-1 Protein Fragment Anticancer Vaccine Response via Macrophage Activation and Polarization Mechanism
- (2015) Teodora Mocan et al. Journal of Cancer
- MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery
- (2014) E. Sayari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Immature truncated O-glycophenotype of cancer directly induces oncogenic features
- (2014) Prakash Radhakrishnan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of a Non-Human Sialic Acid in Human Cancer
- (2014) Annie N. Samraj et al. Frontiers in Oncology
- ‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles as Potential Synthetic Cancer Vaccines
- (2013) Alison L. Parry et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
- (2013) Catarina Gomes et al. PLoS One
- Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169
- (2012) Weihsu C. Chen et al. PLoS One
- Abstract 3485: MM-111, an ErbB2/ErbB3 bispecific antibody with potent activity in ErbB2-overexpressing cells, positively combines with trastuzumab to inhibit growth of breast cancer cells driven by the ErbB2/ErbB3 oncogenic unit
- (2011) Alexandra Huhalov et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
- (2011) E. P. Bennett et al. GLYCOBIOLOGY
- Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
- (2011) Samar Hamdy et al. PHARMACEUTICAL RESEARCH
- Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
- (2011) Chenchen Yu et al. PLoS One
- The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations
- (2011) Y Mishima et al. Blood Cancer Journal
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells
- (2010) Ralf Lutterbuese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Phage Display Derived Therapeutic Antibodies
- (2008) Holger Thie et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now